LALeonard Ogbonna Ajah

Leonard Ogbonna Ajah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leonard Ogbonna Ajah has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Knowledge of mothers regarding prematurity and related problems in Abakaliki, South-East Nigeria

    by Emeka Onwe Ogah, Obumneme Benaiah Ezeanosike, Leonard Ogbonna Ajah, Linda Nwokeji-Onwe, Nnaemeka Kenneth Omeje, Monique Iheoma Ajah, Dorathy Chinwe Obu, Benson Nnamdi Onyire, Samuel Amechi Nwukor, Charity Oluchi Onwe

    Prematurity poses a high financial and psychological burden to the families and healthcare providers. This study was aimed at determining the knowledge of

  • Open Access

    Chlamydia trachomatis infection seroprevalence among women with normal and abnormal cervical smears and its implication for Nigerian cervical cancer screening

    by Tochukwu Dickson Ifezuoke, Monique Iheoma Ajah, Leonard Ogbonna Ajah, Hyginus Uzo Ezegwui, Amaechi Okwudili, Victor Chinazo Duru, Amara Ann Ifezuoke, Ifeanyi John Achara

    The oncogenic human papilloma virus (HPV) causes transient infections of the cervix, hence other co-factors can potentiate the formation of cervical epithelial cell abnormalities. This study was aimed at determining the seroprevalence of Chlamydia trachomatis infection among women with normal and abnormal Papanicolaou smear cytology results. This was a hospital-based cross-sectional comparative study in which study participants were conveniently recruited from January to June,2021. The 50 cases and 50 controls were women with abnormal and normal Papanicolaou smear cytology results respectively. Both groups had blood samples collected for anti- Chlamydia trachomatis antibody test. The data was analyzed with the Statistical Product and Service Solutions (IBM SPSS, Armonk, New York, USA) version 24.0 for windows. The categorical and continuous variables were analyzed with chi square(X2) and Student's t tests respectively. Binary logistic regression analysis was used to determine the associated factors for Chlamydia trachomatis infection among the respondents. P-value < 0.05 was accepted as statistically significant. The overall seroprevalence of Chlamydia trachomatis infection was 27%. Positive Chlamydia infection had a significant association with cervical epithelial cell abnormalities (P- value = 0.001). Positive history of multiple sexual partners and coitarche at age of < 18 years were associated factors for Chlamydia trachomatis infection. This study identified an association between history of Chlamydia trachomatis infection and cervical epithelial cell abnormalities.

  • Open Access

    Efficacy of Tranexamic Acid in Reducing Myomectomy-Associated Blood Loss among Patients with Uterine Myomas at Federal Teaching Hospital Abakaliki: A Randomized Control Trial

    by Ayodele Adegbite Olaleye, Joshua Adeniyi Adebayo, Justus Ndulue Eze, Leonard Ogbonna Ajah, Chidebe Christian Anikwe, John O. Egede, Chidi Ikenna Ebere

    Background. Myomectomy can be associated with life-threatening conditions such as bleeding. Excessive bleeding usually necessitates blood transfusion. Interventions to reduce bleeding during myomectomy will help reduce the need for blood transfusion with its associated complications. Tranexamic acid has been used to reduce bleeding in other surgical procedures, and its usage during myomectomy merits evaluation. Objective. To assess the efficacy of tranexamic acid in reducing myomectomy-associated blood loss. Materials and Methods. This is a prospective double-blinded randomized trial conducted on women who had abdominal myomectomy. Patients were randomized into two groups. The study group received perioperative intravenous tranexamic acid (TXA) while the control group received a placebo. Intraoperative blood loss was calculated by measuring the volume in the suction apparatus and weighing the surgical swabs. In addition, blood collected postoperatively from the wound drains and drapes were measured. Haemoglobin concentrations were determined preoperatively and on second postoperative day for all cases. Any adverse effect was noted in both groups. The data was processed using Epi Info software (7.2.1, CDC, Atlanta, Georgia). The relationships between categorical data were analyzed using and Student’s -test to determine relationships between continuous variables, with a value of 0.05 considered statistically significant, and correlation coefficients were calculated using Pearson’s formula, and probability of 0.05 was set for statistical significance. Results. Symptomatic uterine myomas constituted 17.3% of all gynaecological admissions and 21.3% of gynaecological operations at Federal Teaching Hospital Abakaliki. The mean intraoperative blood loss among patients that had perioperative tranexamic acid infusion was ml, while that of patients with placebo infusion was ml. Perioperative tranexamic acid infusion therefore reduced mean intraoperative blood loss by 300 ml, and this was statistically significant ( , 95% CI: −403.932 to −196.067, ). Perioperative tranexamic acid reduced mean total blood loss by a value of 532.3 ml, and this is statistically significant ( , 95% CI: 393.308 to 670.624, ). Tranexamic acid also improved postoperative haemoglobin concentration by 1.8 g/dl compared with placebo, and this is statistically significant ( , 95% CI: 1.182 to 2.473, ). Tranexamic acid infusion decreased hospital stay by about 2 days, and this difference was statistically significant ( , 95% CI: -3.018 to –0.983, ). There was no adverse drug reaction in the course of the study. Conclusion. The use of tranexamic acid during myomectomy reduced intraoperative and postoperative blood loss. It is also associated with decreased hospital stay. This trial is registered with NCT04560465.


  • Open Access

    Preoperative versus postoperative misoprostol use for prevention of blood loss during caesarean section in pregnant women at term: a multi-centre randomised controlled trial

    by Leonard Ogbonna Ajah, Monique Iheoma Ajah, Hyginus Uzo Ezegwui, Theophilus Ogochukwu Nwankwo, Chukwuemeka Anthony Iyoke, Wilson Ndukwe Nwigboji

    Objective: Caesarean section is associated with higher blood loss than vaginal delivery. This study was performed to compare the safety and efficacy of preoperative versus postoperative rectal and sublingual misoprostol use for prevention of blood loss in women undergoing elective caesarean delivery. Methods: Eligible patients in Southeast Nigeria were randomly classified into those that received 600 µg of preoperative rectal, postoperative rectal, preoperative sublingual, and postoperative sublingual misoprostol. All patients received 10 units of intravenous oxytocin immediately after delivery. Data were analysed with SPSS Version 23. Results: Preoperative sublingual misoprostol use caused the highest postoperative packed cell volume, least change in the packed cell volume, and lowest intraoperative blood loss. Preoperative sublingual and rectal misoprostol use was associated with better haematological indices and maternal outcomes than postoperative use by these routes. However, preoperative sublingual and rectal use caused more maternal side effects than postoperative use by these routes. Conclusion: Preoperative sublingual misoprostol was associated with the most favourable haematological indices. Although preoperative sublingual and rectal misoprostol use caused more maternal side effects, these routes were associated with better haematological indices and maternal outcomes than postoperative sublingual and rectal misoprostol use.

  • Open Access

    Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval

    by Uchenna Anthony Umeh, George Uchenna Eleje, Justus Uchenna Onuh, Ogochukwu Theophilus Nwankwo, Ijeoma Victoria Ezeome, Leonard Ogbonna Ajah, Ngozi Regina Dim, Samuel Nnamdi Obi, Chidebe Christian Anikwe, Joseph Ifeanyichukwu Ikechebelu

    Objectives. The aim of this study is to determine the effect of interpregnancy interval (IPI) on the incidence of placenta previa and placenta accreta spectrum disorders in women with a previous cesarean section. Methods. A prospective cohort three-center study involving parturients who had previous cesarean section was conducted. Participants were included if pregnancy has lasted up to 34 weeks. Parturients with co-existing uterine fibroids, multiple gestations, premature rupture of membranes, and those with prior postcesarean delivery wound infection were excluded. The eligible women recruited were distributed into two groups, namely, short ( p = 0.13 ), respectively. The incidence of placenta accreta spectrum disorder was 1.6% and 0.8% for short and normal IPI (odds ratios = 2.02; 95% confidence intervals = 0.18–22.13; p = 0.57 ), respectively. The only observed significant difference between the clinical variables and placenta previa is the number of cesarean sections ( p = 0.02 ) in women with short IPI. Conclusion. A short interpregnancy interval does not significantly affect the incidence of placenta previa and placenta accreta spectrum disorder following a cesarean section. There is a need for further study with large numbers to corroborate these findings in low- and middle-income settings.


  • Open Access

    A 20 year retrospective study of rape pattern in Ebonyi State, South-East Nigeria

    by Leonard Ogbonna Ajah, Monique Iheoma Ajah, Benjamin Okorie Ajah, Emeka Ogah Onwe, Benjamin Chukwuma Ozumba, Chukwuemeka Anthony Iyoke, Theophilus Ogochukwu Nwankwo, Oguejiofo C.P. Ezeanya


  • The outcome of complementary and alternative medicine use among pregnant women in South-East Nigeria: a multi-centre prospective study

    by Leonard O. Ajah, Hyginus U. Ezegwui, Monique I. Ajah, Chukwuemeka A. Iyoke, Cyril C. Dim, Theophilus O. Nwankwo, Anthony U. Umeh, Arinze Iketuonye

    There is a global increasing trend of complementary and alternative medicine (CAM) use among pregnant women. This study aimed at determining the maternal and perinatal outcome of CAM use among the pregnant women in South-East Nigeria. This was a prospective study in which self-administered semi-structured questionnaires were used to collate information from the consenting pregnant women who use CAM and those who did not use CAM from the gestational age of 36 weeks at four hospitals in South-East Nigeria. Both groups were matched for age, parity and address. Every participant was followed up until delivery. Data were analysed using SPSS version 23 (SPSS Inc., Chicago, IL). This study’s ethical clearance number was NHREC/05/01/2008B-FWA00002458-1RB00002323 and it was obtained at UNTH and on February 15 2019. CAM use in pregnancy was associated with low haemoglobin concentration, maternal complications, high caesarean section rate, low birth weight, low APGAR score, large placental weight and high hospital admission of babies when compared with non-CAM users (p value= <.05). In conclusion, CAM use in pregnancy was associated with poor maternal and perinatal health indices, hence the need to implement policies aimed at reversing them.


  • Analysis of cost burden of obstetric care among human immune-deficiency virus (HIV) positive women in Enugu metropolis, South-East Nigeria

    by J. T. Enebe, L. O. Ajah, N. O. Enebe, E. N. Onwudiwe, I. N. Chikezie, M. I. Ajah, O. E. Onwujekwe

    The cost of obstetric care could hinder the capacity of human immune-deficiency virus (HIV) positive women to receive adequate care during pregnancy and delivery. This study was aimed at determining the relationship between antenatal/delivery care cost and delivery place choice among HIV positive women in Enugu metropolis. This was a cross-sectional study of 232 post-partum HIV-positive women who came for 6-weeks post-natal visit. Data were analysed using SPSS version 20. The ethical clearance number obtained at UNTH on 18/11/2015 was NHREC/05/01/2008BFWA00002458-1RB00002323. The average obstetric care cost among the respondents was N55,405.67 (US$346.28). The delivery cost (p-value-0.043) had positive relationship with delivery place choice. The women's proportion delivered by skilled birth attendants (SBA) was 93.1%. In conclusion, obstetric care cost among HIV positive women in Enugu was high. The high obstetric care cost influenced the delivery place of one-third of them. The choice of ill-equipped health facilities may result in higher risk of HIV transmission.IMPACT STATEMENT What is already known on this subject?The high HIV/AIDs burden in Nigeria could be attributed to poverty, ignorance, corruption and poor implementation of policies targeted at halting the spread of the infection. The cost of obstetric care could hinder the capacity of HIV positive women to receive adequate care during pregnancy and delivery. What do the results of this study add?The cost of antenatal care (p-value = .02) and delivery (p-value = .001) had a significant positive relationship with the choice of place of delivery by the respondents. The proportion of the women delivered by SBA was 93.1%. Approximately 31.9% of the women delivered at the health facilities different from where they had antenatal care. What are the implications of these findings for clinical practice and/or further research?This implies that the obstetric care cost among HIV positive women in Enugu metropolis was catastrophic. Though 93.1% of the respondents were delivered by SBA, the high cost of obstetric care influenced the delivery of one-third of them at centres different from where they had antenatal care. This may lead to women delivering in poorly equipped health facilities, which, in turn, may result in a higher risk of mother-to-child HIV transmission.

  • Open Access

    Association between obesity and abnormal Papanicolau(Pap) smear cytology results in a resource-poor Nigerian setting

    by Silas Onyemaechi Okoro, Leonard Ogbonna Ajah, Peter Onubiwe Nkwo, Uzochukwu U. Aniebue, Benjamin Chukwuma Ozumba, Chibuike Ogwuegbu Chigbu

    Background: Though obesity is associated with some malignancies, its association with cervical cancer is still inconclusive. This study was aimed at determining if there was an association between obesity and cervical epithelial cell abnormalities (CEA). Methods: This was a cross-sectional comparative study of obese and non-obese women at the Cervical Cancer Screening Clinic, University of Nigeria Teaching Hospital (UNTH), Enugu between January, 2012 and June, 2013. The participants whose body mass index (BMI) were ≥ 30 kg/m2 were classified as obese (200 women) while those whose BMI were < 30 kg/m2 were classified as non-obese (200 women) and the two groups were consecutively recruited at the ratio of 1:1. Pap smear cytology, random blood sugar (RBS) and human immune-deficiency virus (HIV) screening was done for all the participants. Data was analyzed with SPSS version 20. Categorical variables were analyzed using McNemar’s test and Chi-squared test. Logistic regression analysis was used to determine the influence of socio-demographic characteristics on cervical epithelial cell abnormalities. The level of significance was set at ≤0.05. Results: Among the obese women, 152(76%) had negative for intra-epithelial lesion or malignancy (NILM) while 48(24%) had cervical epithelial cell abnormalities (CEA). Also 182(91%) non-obese women had NILM while the remaining 18(9%) had CEA. The prevalence of CEA among all the study participants was 16.5%. There was an association between obesity and CEA[OR (95%CI) = 1.353(1.013–1.812); P-value = 0.04].CEA were significantly more common among women who were 40 years and above and single/separated women as well as widows (P-value = < 0.05). Conclusion: There was an association between obesity and CEA. This underscores the need for a positive behavioural change among women in order to stem the tide of this public health problem.